Abstract
Irritable bowel syndrome (IBS) is a highly prevalent chronic functional gastrointestinal (GI) disorder associated with abdominal pain and change in bowel habits that its etiology is not known yet. In the recent years, melatonin has been proposed as a possible candidate. In the present work, all clinical or non-clinical data about effects of melatonin in GI tract and IBS obtained from literature without time limit up to August 2010 have been studied and reviewed. Eight clinical trials were reviewed for the efficacy and disturbance of melatonin in IBS and other GI disorders. The results showed disturbances in endogenous melatonin concentration in IBS patients and significant benefits of exogenous melatonin in these patients by decreasing abdominal pain and improvement of overall IBS symptom scores. The results of seventeen non-clinical studies showed anxiolytic, anti-inflammatory, anti oxidative and motility regulatory effects of melatonin on GI tract. In conclusion, melatonin can be a target of interest in IBS because of its potentials to regulate GI motility.
Keywords: Irritable bowel syndrome, pharmaceutical management, treatment, melatonin, Melatonin Therapy, GI disorders, GI tract, central nervous system, anticholinergics, phosphodiesterase inhibitors, tricyclic antidepressants, 5-hydroxytryptamine-3 (5-HT3) receptor antagonists, peppermint oil, Mellisa officinalis, Aloe vera, 5-methoxy-N-acetyl tryptamine, indolamine, L-tryptophan, N-acetyltransferas, hydroxyindole-O-methyl-transferase, diabetes, Parkinson's disease, colorectal cancer, ulcerative colitis, gastric ulcers, entrochromaffin cells, hydroxyindole-O methyltransferase, esophageal lesions, NF B, proinflammatory cytokines, tumor necrosis factor alpha, Antioxidant Effect, Effect on Prostaglandins, Hydrochloric Acid, Nitric Oxide, Serotonin, Nicotinic Receptors, Cholecystokinin
Current Pharmaceutical Design
Title: Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review
Volume: 16 Issue: 33
Author(s): Shilan Mozaffari, Roja Rahimi and Mohammad Abdollahi
Affiliation:
Keywords: Irritable bowel syndrome, pharmaceutical management, treatment, melatonin, Melatonin Therapy, GI disorders, GI tract, central nervous system, anticholinergics, phosphodiesterase inhibitors, tricyclic antidepressants, 5-hydroxytryptamine-3 (5-HT3) receptor antagonists, peppermint oil, Mellisa officinalis, Aloe vera, 5-methoxy-N-acetyl tryptamine, indolamine, L-tryptophan, N-acetyltransferas, hydroxyindole-O-methyl-transferase, diabetes, Parkinson's disease, colorectal cancer, ulcerative colitis, gastric ulcers, entrochromaffin cells, hydroxyindole-O methyltransferase, esophageal lesions, NF B, proinflammatory cytokines, tumor necrosis factor alpha, Antioxidant Effect, Effect on Prostaglandins, Hydrochloric Acid, Nitric Oxide, Serotonin, Nicotinic Receptors, Cholecystokinin
Abstract: Irritable bowel syndrome (IBS) is a highly prevalent chronic functional gastrointestinal (GI) disorder associated with abdominal pain and change in bowel habits that its etiology is not known yet. In the recent years, melatonin has been proposed as a possible candidate. In the present work, all clinical or non-clinical data about effects of melatonin in GI tract and IBS obtained from literature without time limit up to August 2010 have been studied and reviewed. Eight clinical trials were reviewed for the efficacy and disturbance of melatonin in IBS and other GI disorders. The results showed disturbances in endogenous melatonin concentration in IBS patients and significant benefits of exogenous melatonin in these patients by decreasing abdominal pain and improvement of overall IBS symptom scores. The results of seventeen non-clinical studies showed anxiolytic, anti-inflammatory, anti oxidative and motility regulatory effects of melatonin on GI tract. In conclusion, melatonin can be a target of interest in IBS because of its potentials to regulate GI motility.
Export Options
About this article
Cite this article as:
Mozaffari Shilan, Rahimi Roja and Abdollahi Mohammad, Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review, Current Pharmaceutical Design 2010; 16 (33) . https://dx.doi.org/10.2174/138161210794079254
DOI https://dx.doi.org/10.2174/138161210794079254 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
?Revolutionizing Cancer Treatment: Nano-Therapeutics Targeting Tumor Microenvironment?
This thematic issue explores the forefront of cancer treatment, centering on the groundbreaking potential of nano-therapeutics meticulously designed to target the tumor microenvironment. At its core, the issue aims to unravel the latest advancements in nanotechnology, showcasing innovative materials, formulations, and delivery systems that hold promise for redefining cancer therapeutics. ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke
MicroRNA Managing Expectations in the Transition to Proof of Concept Studies
Reviews on Recent Clinical Trials Assessment of the Usefulness of the SEMA5A Concentration Profile Changes as a Molecular Marker in Endometrial Cancer
Current Pharmaceutical Biotechnology The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges
Current Topics in Medicinal Chemistry Beyond the "Lock and Key" Paradigm: Targeting Lipid Rafts to Induce the Selective Apoptosis of Cancer Cells
Current Medicinal Chemistry Syncytin and GCMa: Key Regulators in Human Placental Physiology and in Pre-Eclampsia
Current Women`s Health Reviews Cellular Regulation of SIRT1
Current Pharmaceutical Design Has the Two Week Rule Improved Cancer Detection Rates for Gastrointestinal Cancers? A Systematic Literature Review
Current Cancer Therapy Reviews Structure, Roles and Inhibitors of a Mitotic Protein Kinase Haspin
Current Medicinal Chemistry Aromatase: The Enzyme and Its Inhibition
Anti-Cancer Agents in Medicinal Chemistry Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Molecular Mechanisms Regulating Matrix Metalloproteinases
Current Topics in Medicinal Chemistry The Anti-Inflammatory and Pharmacological Actions of Oleocanthal, a Phenolic Contained in Extra Virgin Olive Oil
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Antitumor Effects of Celastrol and Semi-Synthetic Derivatives
Mini-Reviews in Organic Chemistry TGFb and its Smad Connection to Cancer
Current Genomics Silencing Human Cancer: Identification and Uses of MicroRNAs
Recent Patents on Anti-Cancer Drug Discovery Connecting A Tumor to the Environment
Current Pharmaceutical Design Interaction of Mesalasine (5-ASA) with Translational Initiation Factors eIF4 Partially Explains 5-ASA Anti-Inflammatory and Anti-Neoplastic Activities
Medicinal Chemistry Review of Synthesis, Assay, and Prediction of β and γ-secretase Inhibitors
Current Topics in Medicinal Chemistry Nanosponges Encapsulated Phytochemicals for Targeting Cancer: A Review
Current Drug Targets